Taiwan Society of Cardiology¯€目表 ok.pdfLiang-Miin Tsai Chen-Chuan Cheng 理事: Executives:...

中華民國心臟學會 Taiwan Society of Cardiology

理事長：林俊立 President: Jiunn-Lee Lin 名譽理事: Honorary Executive Directors: 呂鴻基姜必寧連文彬張茂松謝士明曾淵如

Hung-Chi Lue Benjamin N. Chiang Wen-Pin Lien Mau-Song Chang Shyh-Ming Shieh Yung-Zu Tseng 江志桓李源德江正文江福田陳志鴻林幸榮Chi-Woon Kong Yuan-Teh Lee Cheng-Wen Chiang Fu-Tien Chiang Jyh-Hong Chen Shing-Jong Lin 葉森洲San-Jou Yeh

第一副理事長：潘如濱 The First Vice-President: Ju-Pin Pan 第二副理事長：殷偉賢

The Second Vice-President: Wei-Hsian Yin 常務理事: Executive Board: 吳俊仁侯嘉殷徐國基馬光遠程文俊蔡正道Jiunn-Ren Wu Charles Jia-Yin Hou Kou-Gi Shyu Guang-Yuan Mar Wen-Jin Cherng Cheng-Dao Tsai 蔡良敏鄭成泉

Liang-Miin Tsai Chen-Chuan Cheng

理事: Executives: 王水深王志鴻王俊傑吳彥雯李文領林少琳Shoei-Shen Wang Ji-Hung Wang Chun-Chieh Wang Yen-Wen Wu Wen-Lieng Lee Shoa-Lin Lin 林宗憲侯紹敏洪志凌洪惠風徐迺維常敏之Tsung-Hsien Lin Shaw-Min Hou Chi-Ling Hung Huei-Fong Hung Nai-Wei Hsu Min-Ji Charng 張仁平陳文鍾陳逸忠陳適安陳震寰傅雲慶Jen-Ping Chang Wen-Jone Chen I-Chung Chen Shih-Ann Chen Chen-Huan Chen Yun-Ching Fu 黃崔源黃瑞仁葉宏一蔡建松蔡惟全鄭書孟 Tsuei-Yuan Huang Juey-Jen Hwang Hung-I Yeh Chien-Sung Tsai Wei-Chuan Tsai Shu-Meng Cheng

常務監事: 賴文德 Control Board: Wen-Ter Lai 監事: Controllers: 王主科江晨恩柯文欽柯毓麟洪大川翁國昌Jou-Kou Wang Chern-En Chiang Wen-Chin Ko Yu-Lin Ko Ta-Chuan Hung Kwo-Chang Ueng 張坤正郭啟泰程俊傑褚柏顯Kuan-Cheng Chang Chi-Tai Kuo Jun-Jack Cheng Pao-Hsien Chu

2017年冬季學術研討會籌備委員會

理事長：林俊立

學術委員會主任委員：徐國基學術委員會副主任委員：葉宏一委員：王主科、王俊傑、江晨恩、林宗憲、張坤正、張重義、陳偉踐、陳肇文、黃水坤、黃瑞仁、蔡良敏、蔡惟全、賴文德秘書長：蔡佳醍主副秘書長：謝宜璋副秘書長：林隆君、陳郁志、李政翰、楊甯貽、林佳濱、黃金洲、蔡子賢、蔡維中、何弘棋、張瑋婷、蔡浩元、林廷澤、

吳書豪秘書主任：林玉英秘書：徐婉瑄、黃淑菁、尤婉儒

秘書長:蔡佳醍 Secretary General: Chia-Ti Tsai主副祕書長:謝宜璋 Chief Associate Secretary General: I-Chang Hsieh

副秘書長: Associate Secretary General:林隆君楊甯貽何弘棋吳書豪林廷澤李政翰 Lung-Chun Lin Ning-I Yang Hung-Chi Ho Shu-Hao Wu Ting-Tse Lin Cheng-Han Lee林佳濱張瑋婷陳郁志黃金洲蔡子賢蔡浩元 Chia-Pin Lin Wei-Ting Chang Michael Yu-Chih Chen Chin-Chou Huang Tzu-Hsien Tsai Hao-Yuan Tsai蔡維中 Wei-Chung Tsai

各位敬愛的心臟學會理監事及會員們：

今年的中華民國心臟學冬季會將於12月9-10日週末盛大展開，地

點選定古都台南的大億麗緻酒店，竭誠歡迎學會會員前來尋

「古」探「今」，精進新知。

此次台南冬季會節目紮實而精彩，心臟及血管疾病的介入性治療尤其是第一展現主

題，從心臟外科以達文西機械手臂施行二尖瓣修補及置換手術的現場視訊實況轉播揭

開序幕，同步並連續排出下肢周邊血管疾病(所謂LEAD)新科技、rotational atherectomy困

難案例、各種結構性心臟病的新穎經導管治療技術(包括人工主動脈瓣置換、人工肺動

脈瓣置換、二尖瓣夾、瓣膜置換缺漏矯正)等等。心電生理委員會特別推出心房顫動的

全方位治療策略研討會，從預防性偵測、藥物治療、經導管電燒、冷凍手術、外科開

心手術，至抗凝血劑選擇、左心耳封阻器技術，乃至緊急腦栓塞血栓經導管摘除術，

一次搞懂心房顫動的全面攻克方略。高血壓、預防及介入委員會共同推出高血壓治療

指引、血脂治療指引以及即將完成的非ST段上昇心肌梗塞(NSTEMI)治療指引討論會，廣

泛尋求會員們的治療共識；更難得的，心血管防治的不可或缺主角：戒煙，此次亦由

國民健康署王英偉署長領軍，親自為全體會員於冬季會開設戒煙治療醫師教育訓練課

程，深入心臟科醫師最頭痛的角落，破解戒煙密碼，也為明年國健署整建全國心血管

防治網做準備。有了當今最新的藥物、生活及介入治療新知識，學術、小兒心臟、基

礎、倫理委員會等更為會員們安排新生兒先天性心臟病(從胎兒開始)、幹細胞治療心肌

梗塞／周邊血管疾病、心衰竭共病、心臟癌症學以及臨床試驗GCP學分課程，努力為會

員們提供全面性的新知「冬令」進補，後者為會員們有興趣參與大型臨床試驗做準

備。

冬季會的規格一向是比照每年的年會，內容更是廣泛而具體，目的是加速心臟內、

外、兒科醫學新知的全面傳達，讓所有心臟學會會員與時俱進，走在世界潮流的最前

端，即如歐洲心臟學會年會的焦點新知也以Post-ESC研討會再次展示，務求深烙會員心

中。

理事長的話

敬邀

理事長

各位敬愛的心臟學會理監事及會員們：

今年的中華民國心臟學冬季會將於12月9-10日週末盛大展開，地

點選定古都台南的大億麗緻酒店，竭誠歡迎學會會員前來尋

「古」探「今」，精進新知。

此次台南冬季會節目紮實而精彩，心臟及血管疾病的介入性治療尤其是第一展現主

題，從心臟外科以達文西機械手臂施行二尖瓣修補及置換手術的現場視訊實況轉播揭

開序幕，同步並連續排出下肢周邊血管疾病(所謂LEAD)新科技、rotational atherectomy困

難案例、各種結構性心臟病的新穎經導管治療技術(包括人工主動脈瓣置換、人工肺動

脈瓣置換、二尖瓣夾、瓣膜置換缺漏矯正)等等。心電生理委員會特別推出心房顫動的

全方位治療策略研討會，從預防性偵測、藥物治療、經導管電燒、冷凍手術、外科開

心手術，至抗凝血劑選擇、左心耳封阻器技術，乃至緊急腦栓塞血栓經導管摘除術，

一次搞懂心房顫動的全面攻克方略。高血壓、預防及介入委員會共同推出高血壓治療

指引、血脂治療指引以及即將完成的非ST段上昇心肌梗塞(NSTEMI)治療指引討論會，廣

泛尋求會員們的治療共識；更難得的，心血管防治的不可或缺主角：戒煙，此次亦由

國民健康署王英偉署長領軍，親自為全體會員於冬季會開設戒煙治療醫師教育訓練課

程，深入心臟科醫師最頭痛的角落，破解戒煙密碼，也為明年國健署整建全國心血管

防治網做準備。有了當今最新的藥物、生活及介入治療新知識，學術、小兒心臟、基

礎、倫理委員會等更為會員們安排新生兒先天性心臟病(從胎兒開始)、幹細胞治療心肌

梗塞／周邊血管疾病、心衰竭共病、心臟癌症學以及臨床試驗GCP學分課程，努力為會

員們提供全面性的新知「冬令」進補，後者為會員們有興趣參與大型臨床試驗做準

備。

冬季會的規格一向是比照每年的年會，內容更是廣泛而具體，目的是加速心臟內、

外、兒科醫學新知的全面傳達，讓所有心臟學會會員與時俱進，走在世界潮流的最前

端，即如歐洲心臟學會年會的焦點新知也以Post-ESC研討會再次展示，務求深烙會員心

中。

理事長的話

敬邀

理事長

Prev

iew

Roo

m試

片室

A01

B01

B02

B03

B04

B05

Take

da

No

vart

is

Pfiz

er報到處

Reg

istr

atio

n服務處

Serv

ice

Are

a積分簽到處

Ast

raZe

neca

Men

arin

i

Daiichi Sankyo OEP Aspen UBS

Boeh

ring

erIn

gel

heim

MSD

Act

elio

n

A02

A03

A04

A05

A06

A10

A11

A12

A13

A14

A15

A16

A17

A07

A08

(3F)

富貴廳

Fortu

ne R

oom

大億Ｂ廳

Gra

nd B

all R

oom

B

Prev

iew

Roo

m試

片室

A01

B01

B02

B03

B04

B05

Take

da

No

vart

is

Pfiz

er報到處

Reg

istr

atio

n服務處

Serv

ice

Are

a積分簽到處

Ast

raZe

neca

Men

arin

i

Daiichi Sankyo OEP Aspen UBS

Boeh

ring

erIn

gel

heim

MSD

Act

elio

n

A02

A03

A04

A05

A06

A10

A11

A12

A13

A14

A15

A16

A17

A07

A08

(3F)

富貴廳

Fortu

ne R

oom

大億Ｂ廳

Gra

nd B

all R

oom

B

Prev

iew

Roo

m試

片室

Post

er A

rea

易拉展展示區

(5F)

PRO

GR

AM

AT

A G

LA

NC

E節目一覽表

Dat

e12

/09(

Satu

rday

)

Hea

lthy

Bre

ak

Venu

e

Venu

e

09:0

0

10:3

0

10:3

0

12:0

0

14:0

0

15:3

0

16:0

0

17:3

0

12:1

513

:45

Venu

e

17:4

519

:15

15:3

016

:00

Fortu

ne R

oom

富貴廳

(3F)

Gra

nd B

allro

om B

大億

B廳

(3F)

Ban

quet

Hal

l A 麗緻

A廳

(5F)

Fortu

ne R

oom

富貴廳

(3F)

Ban

quet

Hal

l A 麗緻

A廳

(5F)

Fortu

ne R

oom

富貴廳

(3F)

Ban

quet

Hal

l A 麗緻

A廳

(5F)

Ban

quet

Hal

l B 麗緻

B廳

(5F)

Ban

quet

Hal

l B麗緻

B廳

(5F)

Venu

eFo

rtune

Roo

m 富貴廳

(3F)

Gra

nd B

allro

om B

大億

B廳

(3F)

Ban

quet

Hal

l A 麗緻

A廳

(5F)

Ban

quet

Hal

l B麗緻

B廳

(5F)

JOIN

T C

OM

MIT

TEE

OF

CR

ITIC

AL

CA

RE

ME

DIC

INE

C

ER

TIFI

ED

CO

UR

SE

─ S

AVIN

G

LIFE

ISS

UE

(SAV

ING

LIV

ES

─

CR

UC

IAL

TAS

KS

)

﹝R

EGIS

TRAT

ION

ON

LY﹞

CV

S L

IVE

DE

MO

NS

TRAT

ION

: VA

LVU

LAR

SU

RG

ER

YIN

-DE

PTH

LE

AR

NIN

G O

F E

ND

OVA

SC

ULA

R T

HE

RA

PY

FOR

LO

W E

XTR

EM

ITY

AR

TER

IAL

DIS

EA

SE

(LE

AD

)

WH

AT S

HO

ULD

WE

R

EC

OM

ME

ND

IN T

HE

TS

OC

N

ON

ST-

SE

GM

EN

T E

LEVA

TIO

N

AC

S G

UID

ELI

NE

?

QU

AN

TIFI

CAT

ION

OF

VALV

ULA

R H

EA

RT

DIS

EA

SE

S

BY

EC

HO

CA

RD

IOG

RA

PH

Y

2017

PO

ST

ES

C H

IGH

LIG

HT

SY

MP

OS

IUM

(I)

TOTA

L S

OLU

TIO

N F

OR

ATI

AL

FIB

RIL

LATI

ON：

PAR

T I

UP

DAT

E H

YP

ER

TEN

SIO

N

GU

IDE

LIN

ES

AN

D R

EA

L W

OR

LD S

TRAT

EG

Y

CO

NG

EN

ITA

L A

ND

STR

UC

TAL

HE

AR

T D

ISE

AS

ES

(PA

RT

I):FR

OM

FE

TUS

TO

CH

ILD

RE

N

2017

PO

ST

ES

C H

IGH

LIG

HT

SY

MP

OS

IUM

(II)

Eve

ning

Sym

posi

um﹝

Nov

artis﹞

Eve

ning

Sym

posi

um﹝

Pfiz

er﹞

Lunc

heon

Sym

posi

um﹝

Ast

raZe

neca﹞

Lunc

heon

Sym

posi

um﹝

Take

da﹞

Lunc

heon

Sym

posi

um﹝

Men

arin

i﹞

TOTA

L S

OLU

TIO

N F

OR

ATI

AL

FIB

RIL

LATI

ON：

PAR

T II

SY

MP

OS

IUM

ON

LIP

ID

TRE

ATM

EN

T C

ON

GE

NIT

AL

AN

D S

TRU

CTA

L H

EA

RT

DIS

EA

SE

S (P

AR

T II)

: FR

OM

ADO

LESC

ENCE

TO

ADU

LTS

SY

MP

OS

IUM

ON

C

AR

DIO

-ON

CO

LOG

Y

(P01

)

(P07

)

(P24

)

(P27

)

(P25

)

(P28

)

(P26

)

(P09

)(P

11)

(P13

)

(P08

)(P

10)

(P12

)(P

14)

(P02

)(P

03)

(P05

)

(P04

)(P

06)

PRO

GR

AM

AT

A G

LA

NC

E節目一覽表

10:0

010

:30

Lunc

heon

Sym

posi

um﹝

Am

gen﹞

Lunc

heon

Sym

posi

um﹝

Pfiz

er﹞

Dat

e12

/10(S

unda

y)

Venu

e

08:3

0

10:0

0

10:3

0

12:0

0

12:1

513

:45

Fortu

ne R

oom

富貴廳

(3F)

醫療法規

: G

CP

CO

UR

SE

(I)

﹝R

EGIS

TRAT

ION

ON

LY﹞

戒煙治療醫師

教育訓練基礎課程

﹝R

EGIS

TRAT

ION

ON

LY﹞

Gra

nd B

allro

om B

大億

B廳

(3F)

Ban

quet

Hal

l A麗緻

A廳

(5F)

Venu

eFo

rtune

Roo

m富貴廳

(3F)

Gra

nd B

allro

om B

大億

B廳

(3F)

Ban

quet

Hal

l B麗緻

B廳

(5F)

Vict

ory

Roo

m常紅廳

(5F)

STE

M C

ELL

TH

ER

AP

Y —

FR

OM

BE

NC

H W

OR

K T

O

CLI

NIC

AL

AP

PLI

CAT

ION

RO

TATI

ON

AL

ATH

ER

EC

TOM

YH

EA

RT

FAIL

UR

E, C

OP

D,

CK

D C

O-M

OR

BID

ITIE

S —

W

HAT

SH

ALL

WE

DO

?

醫療法規

: G

CP

CO

UR

SE

(II)

﹝R

EGIS

TRAT

ION

ON

LY﹞

AN

TI-IN

FLA

MM

ATO

RY

DTR

ATE

GY

IN

CA

RD

IOVA

SC

ULA

R D

ISE

AS

ES

STR

UC

TUR

AL

HE

AR

T D

ISE

AS

ETH

E D

EV

ELO

PM

EN

T A

ND

IM

PAC

T O

F IC

D-1

0 IN

C

AR

DIO

LOG

Y

Hea

lthy

Bre

ak

(P29

)(P

30)

(P15

)(P

17)

(P19

)(P

21)

(P23

)

(P16

)(P

18)

(P20

)(P

22)

PRO

GR

AM

AT

A G

LA

NC

E節目一覽表

10:0

010

:30

Lunc

heon

Sym

posi

um﹝

Am

gen﹞

Lunc

heon

Sym

posi

um﹝

Pfiz

er﹞

Dat

e12

/10(S

unda

y)

Venu

e

08:3

0

10:0

0

10:3

0

12:0

0

12:1

513

:45

Fortu

ne R

oom

富貴廳

(3F)

醫療法規

: G

CP

CO

UR

SE

(I)

﹝R

EGIS

TRAT

ION

ON

LY﹞

戒煙治療醫師

教育訓練基礎課程

﹝R

EGIS

TRAT

ION

ON

LY﹞

Gra

nd B

allro

om B

大億

B廳

(3F)

Ban

quet

Hal

l A麗緻

A廳

(5F)

Venu

eFo

rtune

Roo

m富貴廳

(3F)

Gra

nd B

allro

om B

大億

B廳

(3F)

Ban

quet

Hal

l B麗緻

B廳

(5F)

Vict

ory

Roo

m常紅廳

(5F)

STE

M C

ELL

TH

ER

AP

Y —

FR

OM

BE

NC

H W

OR

K T

O

CLI

NIC

AL

AP

PLI

CAT

ION

RO

TATI

ON

AL

ATH

ER

EC

TOM

YH

EA

RT

FAIL

UR

E, C

OP

D,

CK

D C

O-M

OR

BID

ITIE

S —

W

HAT

SH

ALL

WE

DO

?

醫療法規

: G

CP

CO

UR

SE

(II)

﹝R

EGIS

TRAT

ION

ON

LY﹞

AN

TI-IN

FLA

MM

ATO

RY

DTR

ATE

GY

IN

CA

RD

IOVA

SC

ULA

R D

ISE

AS

ES

STR

UC

TUR

AL

HE

AR

T D

ISE

AS

ETH

E D

EV

ELO

PM

EN

T A

ND

IM

PAC

T O

F IC

D-1

0 IN

C

AR

DIO

LOG

Y

Hea

lthy

Bre

ak

(P29

)(P

30)

(P15

)(P

17)

(P19

)(P

21)

(P23

)

(P16

)(P

18)

(P20

)(P

22)

JOINT COMMITTEE OF CRITICAL CARE MEDICINE CERTIFIED COURSE ─ SAVING LIFE ISSUE (SAVING LIVES─ CRUCIAL TASKS)

CVS LIVE DEMONSTRATION: VALVULAR SURGERY

IN-DEPTH LEARNING OF ENDOVASCULAR THERAPY FOR LOW EXTREMITY ARTE-RIAL DISEASE (LEAD)

WHAT SHOULD WE RECOMMEND IN THE TSOC NON ST-SEGMENT ELEVATION ACS GUIDELINE?

QUANTIFICATION OF VALVULAR HEART DISEASES BY ECHOCARDIOGRAPHY

SYMPOSIUM ON CARDIO-ONCOLOGY

2017 POST ESC HIGHLIGHT SYMPOSIUM (I)

2017 POST ESC HIGHLIGHT SYMPOSIUM (II)

TOTAL SOLUTION FOR ATIAL FIBRILLATION：PART I

TOTAL SOLUTION FOR ATIAL FIBRILLATION：PART II

UPDATE HYPERTENSION GUIDELINES AND REAL WORLD STRATEGY

SYMPOSIUM ON LIPID TREATMENT

CONGENITAL AND STRUCTAL HEART DISEASES (PART I):FROM FETUS TO CHILDREN

CONGENITAL AND STRUCTAL HEART DISEASES (PART II): FROM ADOLESCENCE TO ADULTS

醫療法規: GCP COURSE (I)

醫療法規: GCP COURSE (II)

STEM CELL THERAPY — FROM BENCH WORK TO CLINICAL APPLICATION

ANTI-INFLAMMATORY DTRATEGY IN CARDIOVASCULAR DISEASES

ROTATIONAL ATHERECTOMY

STRUCTURAL HEART DISEASE

HEART FAILURE, COPD, CKD CO-MORBIDITIES — WHAT SHALL WE DO?

THE DEVELOPMENT AND IMPACT OF ICD-10 IN CARDIOLOGY

戒煙治療醫師教育訓練基礎課程

SATELLITE SYMPOSIA

01

02

03

04

05

06

07

08

09

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

CONTENTS PAGE

1

JOINT COMMITTEE OF CRITICAL CARE MEDICINE CERTIFIED COURSE ─ SAVING LIFE ISSUE (SAVING LIVES─ CRUCIAL TASKS)

CVS LIVE DEMONSTRATION: VALVULAR SURGERY

IN-DEPTH LEARNING OF ENDOVASCULAR THERAPY FOR LOW EXTREMITY ARTE-RIAL DISEASE (LEAD)

WHAT SHOULD WE RECOMMEND IN THE TSOC NON ST-SEGMENT ELEVATION ACS GUIDELINE?

QUANTIFICATION OF VALVULAR HEART DISEASES BY ECHOCARDIOGRAPHY





TOTAL SOLUTION FOR ATIAL FIBRILLATION：PART II

UPDATE HYPERTENSION GUIDELINES AND REAL WORLD STRATEGY


CONGENITAL AND STRUCTAL HEART DISEASES (PART I):FROM FETUS TO CHILDREN

CONGENITAL AND STRUCTAL HEART DISEASES (PART II): FROM ADOLESCENCE TO ADULTS

醫療法規: GCP COURSE (I)

醫療法規: GCP COURSE (II)

STEM CELL THERAPY — FROM BENCH WORK TO CLINICAL APPLICATION

ANTI-INFLAMMATORY DTRATEGY IN CARDIOVASCULAR DISEASES



HEART FAILURE, COPD, CKD CO-MORBIDITIES — WHAT SHALL WE DO?

THE DEVELOPMENT AND IMPACT OF ICD-10 IN CARDIOLOGY

戒煙治療醫師教育訓練基礎課程

SATELLITE SYMPOSIA

01

02

03

04

05

06

07

08

09

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

CONTENTS PAGE

1

12 月 9 日〈星期六〉09:00-12:00 SATURDAY, DECEMBER 9, 2017

台南大億麗緻酒店三樓富貴廳

FORTUNE ROOM (3F), TAYIH LANDIS TAINAN

JOINT COMMITTEE OF

CRITICAL CARE MEDICINE CERTIFIED COURSE ─

SAVING LIFE ISSUE (SAVING LIVES─CRUCIAL TASKS)

拯救生命之關鍵任務

﹝REGISTRATION ONLY﹞

09:00 Opening Remarks…………………………………………………….……..……….蔡良敏

(Liang-Miin Tsai)

Chair: 羅鴻舜 (Hung-Shun Lo)

09:10 Heart Saving：Sudden Cardiac Death Strategy…………………………………王晨旭

(Chen-Hsu Wang)

Chair: 簡立健 (Li-Chien Chien )

09:50 New Thoughts on Old Thoracic Injuries……………................…………….......顏亦廷

(Yi-Ting Yen)

Chair: 林立人 (Li-Jen Lin)

10:30 Brain Saving：Hypothermia Therapy…………………………....................…....許志新

(Chih-Hsin Hsu)

Chair: 許志新 (Chih-Hsin Hsu)

11:10 Energy Preservation：Nutritional Support…………………………..................李威廷

(Wei-Ting Li)

11:50 Closing Remarks…………………………......……………………………………....林昌琦

(Chang-Chyi Lin)

2


Demo：台南奇美醫院 Chi Mei Medical Center Chi Mei Hospital

Lecture：台南大億麗緻酒店三樓大億 B 廳 Grand Ballroom B (3F),

Tayih Landis Tainan

LIVE DEMONSTRATION VALVULAR SURGERY

09:00 Opening Remarks…………………………......……………………………....張重義

(Chung-I Chang)

09:05-11:55

Chairs：羅傳堯(Chwan-Yau Luo)、張仁平(Jen-Ping Chang)

Commentators：許榮彬(Ron-Bin Hsu)、謝世榮(Shih-Rong Hsieh)、

張兼華(Chien-Hwa Chang)

Side Lecture

09:15-09:30 Valve-sparing Aortic Root Replacement:

Single Surgeon Experience….................................................................許榮彬

(Ron-Bin Hsu)

09:45-10:00 Total Aortic Root External Wrapping as an Aortic Valve Sparing Aortic

Root Reconstruction and as an Aortic Valve Repair Operation: My

Modification…………………………......………….............................……...謝世榮

(Shih-Rong Hsieh)

10:15-10:30 The Latest Advances in Aortic Valve Surgery……......…………………….羅傳堯

(Chwan-Yau Luo)

10:45-11:00 Tips for Aortic Valve and Root Surgery: State-of-the-Art……..…….....張仁平

(Jen-Ping Chang)

11:00-11:15 Tips and Tricks for Mitral Valve Surgery…………………………......…...張兼華

(Chien-Hwa Chang)

11:55 Closing Remarks……………………………………………………………....張仁平

(Jen-Ping Chang)

Da Vinci Mitral Valve Replacement……..Chi Mei Medical Center Chi Mei Hospital：

Operator：鄭伯智(Bor-Chih Cheng)

3


台南大億麗緻酒店五樓麗緻 A 廳

Banquet Hall A (5F), Tayih Landis Tainan

IN-DEPTH LEARNING OF ENDOVASCULAR THERAPY FOR LOW

EXTREMITY ARTERIAL DISEASE (LEAD)

08:50 Opening Remarks…………………………………………………………………….程俊傑

(Jun-Jack Cheng)

Chair: 曾維功 (Wei-Kung Tseng)

08:55 Epidemiology: Current Status of Atherosclerotic LEAD and

Treatment Options in Taiwan……………………………………………………....許栢超

(Po-Chao Hsu)

Chair: 馬光遠 (Guang-Yuan Mar)

09:13 Technique: Clinical Application of Advanced Endovascular

Techniques in Patients with LEAD………………………………………………....吳敘平

(Hsu-Ping Wu)

Chair: 李政翰 (Cheng-Han Lee)

09:31 Device: Efficacy of New Devices in LEAD Interventions

and Updated Results………………………………………………………………...薛書凱

(Shu-Kai Hsueh)

Chair: 徐中和 (Chung-Ho Hsu)

09:49 Imaging: Imaging Modalities to Assess the Tissue

Perfusion after Revascularization………………………………………………….陳俊吉

(Chun-Chi Chen)

Chair: 陳志成 (Zhih-Cherng Chen)

10:07 Prognosis: Treatment Algorithm and Outcome Predictors in LEAD

Patients who have Undergone Endovascular Therapy…………………………黃玄禮

(Hsuan-Li Huang)

10:25 Closing Remarks……………………………………………………………………...趙庭興

(Ting-Hsing Chao)

Each Lecture with 15 Minutes Talk and 3 Minutes Discussion

3

3




IN-DEPTH LEARNING OF ENDOVASCULAR THERAPY FOR LOW

EXTREMITY ARTERIAL DISEASE (LEAD)

08:50 Opening Remarks…………………………………………………………………….程俊傑

(Jun-Jack Cheng)

Chair: 曾維功 (Wei-Kung Tseng)

08:55 Epidemiology: Current Status of Atherosclerotic LEAD and

Treatment Options in Taiwan……………………………………………………....許栢超

(Po-Chao Hsu)

Chair: 馬光遠 (Guang-Yuan Mar)

09:13 Technique: Clinical Application of Advanced Endovascular

Techniques in Patients with LEAD………………………………………………....吳敘平

(Hsu-Ping Wu)

Chair: 李政翰 (Cheng-Han Lee)

09:31 Device: Efficacy of New Devices in LEAD Interventions

and Updated Results………………………………………………………………...薛書凱

(Shu-Kai Hsueh)

Chair: 徐中和 (Chung-Ho Hsu)

09:49 Imaging: Imaging Modalities to Assess the Tissue

Perfusion after Revascularization………………………………………………….陳俊吉

(Chun-Chi Chen)


10:07 Prognosis: Treatment Algorithm and Outcome Predictors in LEAD

Patients who have Undergone Endovascular Therapy…………………………黃玄禮

(Hsuan-Li Huang)

10:25 Closing Remarks……………………………………………………………………...趙庭興

(Ting-Hsing Chao)

Each Lecture with 15 Minutes Talk and 3 Minutes Discussion

4

4




WHAT SHOULD WE RECOMMEND IN THE TSOC NON ST-SEGMENT

ELEVATION ACS GUIDELINE?

10:30 Opening Remarks…………………………………………………………………….林俊立

(Jiunn-Lee Lin)

Chair: 詹貴川 (Kuei-Chuan Chan)

10:35 What NSTE-ACS Guideline should We Have in Taiwan?

Science and the Real World…………………………………………………...……李貽恆

(Yi-Heng Li)

Chair: 顏學偉 (Hsueh-Wei Yen)

10:45 High-sensitivity Troponin for NSTE-ACS: Should High-sensitivity

Troponin be the Standard in Taiwan and should We Use 0/3 hour

Protocol to Diagnose NSTE-ACS ?.………………………………………………..邱俊仁

(Chiung-Zuan Chiu)

11:00 Discussion

Chair: 曾春典 (Chuen-Den Tseng)

11:10 New P2Y12 Inhibitor for NSTE-ACS: Should Ticagrelor or Prasugrel

be the First Line P2Y12 Inhibitor Instead of Clopidogrel in Taiwan and

What dose of Ticagrelor or Prasugrel should We Recommend?……………..王宇澄

(Yu-Chen Wang)

11:25 Discussion

Chair: 林楨智 (Jen-Jyh Lin)

11:35 Invasive Strategy for NSTE-ACS: What is the Right Timing for Coronary

Angiography in Taiwan and What Time (< 3 Hours, < 24 Hours or others)

should We Recommend for Patients with High Rrisk Features?……………...陳俊吉

(Chun-Chi Chen)

11:50 Discussion

12:00 Conclusion and Closing Remarks………………………………….………………李貽恆

(Yi-Heng Li)

5

5


台南大億麗緻酒店五樓麗緻 B 廳

Banquet Hall B (5F), Tayih Landis Tainan

QUANTIFICATION OF VALVULAR HEART DISEASES BY

ECHOCARDIOGRAPHY

09:00 Opening Remarks………………………………….…………………………………溫文才

(Wen-Chol Voon)

Chair: 溫文才 (Wen-Chol Voon)

09:05 Quantification of Mitral Stenosis………………………………….……………….簡振宇

(Chen-Yu Chien)

09:25 Quantification of Mitral Regurgitation………………………………….…….….梁馨月

(Hsin-Yueh Liang)

Chair: 李道輿 (Tao-Yu Lee)

09:45 Quantification of Aortic Stenosis………………………………….……….……...劉嚴文

(Yen-Wen Liu)

10:05 Quantification of Aortic Regurgitation………………………………….….…….施志遠

(Jhih-Yuan Shih)

10:25 Closing Remarks………………………………….…………….………….………...李道輿

(Tao-Yu Lee)

6

6





10:30 Opening Remarks………………………………………………….……….………..劉秉彥

10:35

(Ping-Yen Liu)

Chair: 劉秉彥 (Ping-Yen Liu)

Cancer Therapy-Related Cardiac Dysfunction and a Single Center Experience

Sharing…………………………….............................…….………………….…………….…………...劉嚴文

(Yen-Wen Liu)

10:55 Discussion


11:00 Cardio-Oncology in Taiwan─Three Year Experience Sharing…………….…..張瑋婷

(Wei-Ting Chang)

11:20

11:25

Discussion

Chair: 賴文德 (Wen-Ter Lai)

What Have We Learned from A Case of Uterine Leiomyosarcoma?..............…鄭凱鴻(Kai-Hung Cheng)

11:35 What Have We Learned from A Case of Transitional Cell Carcinoma--Gemcitabine Related Cardiotoxicity?…….................................................…陳政瑋

(Zheng-Wei Chen)

11:45 Discussion

11:55 Closing Remarks………….……………………….……………………….…………賴文德

(Wen-Ter Lai)

7



Fortune Room (3F), Tayih Landis Tainan


14:00 Opening Remarks…………………………………………………..……………..…林俊立

(Jiunn-Lee Lin)

Chair:陳志鴻 (Jyh-Hong Chen)

14:05 Late Breaking Clinical Trials…………………………………………..………….…邱俊仁

(Chiung-Zuan Chiu)

14:30 Hypertension…………………………………………..……………………………..翁國昌

(Kwo-Chang Ueng)

Chair:林幸榮(Shing-Jong Lin)

14:50 Lipids……………………………………..……….……………………..……………..趙庭興

(Ting-Hsing Chao)

15:10 Cardiac Imaging……………………………………..………………..……….……..吳彥雯

(Yen-Wen Wu)

7

7





14:00 Opening Remarks…………………………………………………..……………..…林俊立

(Jiunn-Lee Lin)

Chair:陳志鴻 (Jyh-Hong Chen)

14:05 Late Breaking Clinical Trials…………………………………………..………….…邱俊仁

(Chiung-Zuan Chiu)

14:30 Hypertension…………………………………………..……………………………..翁國昌

(Kwo-Chang Ueng)

Chair:林幸榮(Shing-Jong Lin)

14:50 Lipids……………………………………..……….……………………..……………..趙庭興

(Ting-Hsing Chao)

15:10 Cardiac Imaging……………………………………..………………..……….……..吳彥雯

(Yen-Wen Wu)

8

8





Chair:葉森洲(San-Jou Yeh)

16:00 Heart Failure……………………………………..…………………………...……….洪崇烈

(Chung-Lieh Hung)

16:20 Arrhythmias…………………………………..………………..…………..………….張坤正

(Kuan-Cheng Chang)

Chair:江福田(Fu-Tien Chiang)

16:40 Basic Sciences…………..……………………..………………..…………………….劉秉彥

(Ping-Yen Liu)

17:00 Intervention…………..…………..…………..…………..…………..…………..…..黃啟宏

(Chi-Hung Huang)

17:25 Closing Remarks………..…………..…………..…………..…………..……………徐國基

(Kou-Gi Shyu)

9

9


台南大億麗緻酒店三樓大億� B� 廳

Grand Ballroom B (5F), Tayih Landis Tainan


14:00 Opening Remarks…………………………………..………………..…………..…..張坤正

(Kuan-Cheng Chang)

Chairs:張坤正 (Kuan-Cheng Chang)、溫明賢(Ming-Shien Wen)

14:05 New Device for AF Screening…………………………………..…………………..林亮宇

(Lian-Yu Lin)

14:25 Oral Anti-coagulants and Anti-arrhythmics for AF Treatment………………..陳儒逸

(Ju-Yi Chen)

14:45 New Features of Permanent Pacemaker to Reduce AF Burden………………王俊傑

(Chun-Chieh Wang)

15:05 CRT in AF: When to Implant and How to Optimize…..................................……李坤泰

(Kun-Tai Lee)

15:25 Panel Discussion

10

10


台南大億麗緻酒店三樓大億� B� 廳


TOTAL SOLUTION FOR ATRIAL FIBRILLATION：PART II

Chairs:黃水坤 (Shoei K. Stephen Huang)、陳勉成(Mien-Cheng Chen)

16:00 AF Ablation：Fire or Ice? …………………………………………………………...林晏年

(Yen-Nien Lin)

16:20 Surgical Procedure for AF…………..……...……..……..……..…………………...張仁平

(Jen-Ping Chang)

16:40 LEFT ATRIAL APPENDAGE OCCLUSION (LAAO) IN PATIENTS WITH ATRIAL FIBRILLATION— UPDATED CLINICAL TRIALS………………………………….........…….蔡佳醍

(Chia-Ti Tsai)

17:00 Endovascular Thrombectomy for Patients with Acute IschemicStroke and Large Vessel Occlusion: Single Center Experience…................…嚴寶勝

(Pao-Sheng Yen)


17:25 Closing Remarks……………………………………………………………………...陳勉成

(Mien-Cheng Chen)

11

11




UPDATE HYPERTENSION GUIDELINES AND

REAL WORLD STRATEGY

﹝ENGLISH﹞

14:00 Opening Remarks…………………………………………………………………….陳震寰

(Chen-Huan Chen)

Chair: 陳震寰(Chen-Huan Chen)

14:05 Comparison of AHA/ACC and ESC HT Guidelines………………...Giuseppe Mancia

Chair: 吳彥雯(Yen-Wen Wu)


Chair: 劉秉彥(Ping-Yen Liu)

14:35 What Is Your Blood Pressure Target on Chronic Kidney Disease? …………...葉宏一

(Hung-I Yeh)

14:55 What Is Your Blood Pressure Target Among the Elderly? ……………….........許智能

(Chih-Neng Hsu)


15:25 Closing Remarks………………………….…………...……………….………….....李貽恆

(Yi-Heng Li)

1212





16:00 Opening Remarks…….…………….…………….…….……….…………….……..葉宏一

(Hung-I Yeh)

Chair: 蔡良敏(Liang-Miin Tsai)

16:05 Comparison of Lipid Targets Between Different Guidelines….…………….…李貽恆

(Yi-Heng Li)

Chair: 顏學偉(Hsueh-Wei Yen)

16:25 How to get with the guideline in daily practice? ….…………….………….…...許栢超

(Po-Chao Hsu)

Chair: 陳志成(Zhih-Cherng Chen)

16:45 How low is the low in LDL-cholesterol? ….…………….………………………...張瑋婷

(Wei-Ting Chang)

17:05

Chair: 葉宏一(Hung-I Yen)

Panel Discussion

17:25 Closing Remarks….…………….………….…………….………….…………………陳怡

(Yi Chen)

1313




CONGENITAL AND STRUCTAL HEART DISEASES (PART I):

FROM FETUS TO CHILDREN

先天及結構性心臟病(上)：由胎兒到兒童

14:00 Opening Remarks……….………….…………….…….……………………………吳俊仁

(Jiunn-Ren Wu)

Chairs:吳俊仁 (Jiunn-Ren Wu)、劉萬雄(Won-Hsiung Liu)

14:05 Fetus CHD：Detection and Management…….………….…………...…………徐仲豪

(Jong-Hau Hsu)

14:25 Screening of Neonates with Critical Congenital Heart Disease...……...……...謝旻玲

(Min-Ling Hsieh)

14:45 Medical Management of Heart Failure in Neonates and Young Children….林竹川

(Chu-Chuan Lin)

15:05 Surgical Management of Neonates and Young Children with CHD…………潘俊彥

(Jun-Yen Pan)


14

14




CONGENITAL AND STRUCTAL HEART DISEASES (PART II):

FROM ADOLESCENCE TO ADULTS

先天及結構性心臟病(下)：由青少年到成年

Chairs:戴任恭 (Zen-Kong Dai)、謝凱生(Kai-Sheng Hsieh)

16:00 Follow Up and Management in Grown-up CHD…….…………...……………..黃建冨

(Chien-Fu Huang)

16:20 Pregnancy in Women with CHD…….…………...……………….…….………….盧俊維

(Chun-Wei Lu)

16:40 Arrhythmia Management in Adult CHD Patients…….…………...…………….吳焜烺

(Kun-Lang Wu)

17:00 Catheter Management of Adults with CHD…….…………...……………..........王玠能

(Jieh-Neng Wang)


17:25 Closing Remarks…….…………...……………..….…………...……………..........戴任恭

(Zen-Kong Dai)

15

12 月 10 日〈星期日〉08:30-10:00 SUNDAY, DECEMBER 10, 2017



醫療法規：GCP COURSE (I)

08:30 Opening Remarks…….…………...……………..….…………...…………….........柯文欽

(Wen-Chin Ko)

Chair: 柯文欽(Wen-Chin Ko)

08:40 人體研究法、GCP 及常見試驗偏差……...……………..….………...……………...孫淑慧

(Shu-Hui Sun)


15

15




醫療法規：GCP COURSE (I)

08:30 Opening Remarks…….…………...……………..….…………...…………….........柯文欽

(Wen-Chin Ko)

Chair: 柯文欽(Wen-Chin Ko)

08:40 人體研究法、GCP 及常見試驗偏差……...……………..….………...……………...孫淑慧

(Shu-Hui Sun)


16

16




醫療法規：GCP COURSE (II)

Chair:吳彥雯(Yen-Wen Wu)

10:30 細胞治療臨床試驗之倫理議題與申請作業程序……………..………………..………..連群

(Chris C. Lien)


11:50 Closing Remarks…………..………………………..………………………..………吳彥雯

(Yen-Wen Wu)

17

17


台南大億麗緻酒店三樓大億 B 廳


STEM CELL THERAPY：FROM BENCH WORK TO CLINICAL

APPLICATION

Chairs:賴文德(Wen-Ter Lai)、徐國基(Kou-Gi Shyu)

08:30 Recent Advance in Clinical Trials with Autologous CD34+ Cell Therapy for End-

stage Diffuse Coronary Artery Disease in Taiwan…………..………….……..….李芳艷

(Fan-Yen Lee)

08:50 Recent Advance in Clinical Trials with Autologous CD34+ Cell Therapy for Chronic

Kidney Disease in Taiwan…………..………….………………...……………..…….宋沛勳

(Pei-Hsun Sung)


Chairs:陳偉踐(Wei-Jan Chen)、蘇正煌(Cheng-Huang Su)

09:15 Current Status of Therapeutic Angiogenesis with Stem Cells for the Patients with

Peripheral Arterial Disease……..………...................……………………………...黃柏勳

(Po-Hsun Huang)

09:35 In its right perspective of Stem cell therapy: from bench work to

clinical application…….…………….…………….….………………………………..葉漢根

(Hon-Kan Yip)


18

18




ANTI-INFLAMMATORY STRATEGY IN CARDIOVASCULAR DISEASES

Chairs: 劉秉彥 (Ping-Yen Liu)、王朝永 (Chao-Yung Wang)

10:30 Role of Inflammatory Process in Atherosclerosis: Animal Model….……………賴弘岳

(Hong-Yue Lai)

10:50 Inflammatory Profile on Cardiomyopathy: from Bench to Bedside….…….......張瑋婷

(Wei-Ting Chang)


Chairs: 陳肇文(Jaw-Wen Chen)、顏學偉 (Hsueh-Wei Yen)

11:15 Evidence Based Medicine: What Can We Apply in the Real World Practice?…曹承榮

(Chen-Rong Tsao)


19

19





08:30 Opening Remarks….…………….…………….…………….…………….………...黃瑞仁

(Juey-Jen Hwang)

Chair: 劉世奇 (Shih-Chi Liu)

08:35 Rotational Atherectomy for Left Main Disease….…….…………...….………...曹殿萍

(Tien-Ping Tsao)

Chair: 陳逸忠 (I-Chung Chen)

08:50 Rescue Rotablation for Spiral Dissection….…………….…………….…………王志鴻

(Ji-Hung Wang)

Chair: 林楨智 (Jen-Jyh Lin)

09:05 Rotational Atherectomy in Long Diffuse Lesion….………………….….………李政翰

(Cheng-Han Lee)

Chair: 顧博明 (Po-Ming Ku)

09:20 Rota Burr Entrapment and Management.………................…….……………...李文領

(Wen-Lieng Lee)

Chair: 王志鴻 (Ji-Hung Wang)


09:55 Closing Remarks.…………….…………….…………………….………….…….…王志鴻

(Ji-Hung Wang)

20

20





10:30 Opening Remarks.…………….…………….…………………………….…………謝宜璋

(I-Chang Hsieh)

Chair: 殷偉賢(Wei-Hsian Yin)

10:35 Trans-catheter Intervention for PVL (Para-valvular Leak).……………………..傅雲慶

(Yun-Ching Fu)

Chair: 洪志凌 (Chi-Ling Hung)

10:50 MitraClip (Percutaneous Mitral Valve Repair) …………………………………..殷偉賢

(Wei-Hsian Yin)


11:05 TAVI (Transcatheter Aortic Valve Implantation) 2017................…………………陳嬰華(Ying-Hwa Chen)

Chair: 詹貴川 (Kuei-Chuan Chan)

11:20 Transcatheter Pulmonary Valve Replacement (TPVR) …………………………王主科

(Jou-Kou Wang)

Chair: 殷偉賢 (Wei-Hsian Yin)


11:55 Closing Remarks……………………………………………………………………...殷偉賢

(Wei-Hsian Yin)

21

21




HEART FAILURE, COPD, CKD CO-MORBIDITIES – WHAT SHALL WE DO?

08:30 Opening Remarks…………………………………………………………………….王俊傑

(Chun-Chieh Wang)

Chair: 王俊傑 (Chun-Chieh Wang)

08:33 Diagnosis and Treatment of HF in CKD Patients-Cardiologist’s View……….顏學偉

(Hsueh-Wei Yen)

08:51 Diagnosis and Treatment of CKD in HF Patients-Nephrologist’s View……...田亞中

(Ya-Chung Tian)

Chair: 李啟明 (Chii-Ming Lee)

09:09 Diagnosis and Treatment of HF in COPD Patients-Cardiologist’s View……..洪正中

(Cheng-Chung Hung)

09:27 Diagnosis and Treatment of COPD in HF Patients-Pulmonologist’s View….楊聰明

(Tsung-Ming Yang)


09:57 Closing Remarks……………………………………………………………………...李啟明

(Chii-Ming Lee)

22

22




THE DEVELOPMENT AND IMPACT OF ICD-10 IN

CARDIOLOGY

Chairs: 徐迺維 (Nai-Wei Hsu)、鍾政達(Cheng-Ta Chung)

10:30 目前 ICD10 在心臟科執行現況……………………………………………..魏秀美

(Hsiu-Mei Wei)

11:00 目前 ICD10 在心臟科執行所面臨的問題…………………………………..徐迺維

(Nai-Wei Hsu)


備註：歡迎各醫院心臟科(內科、外科及小兒科)負責健保業務之醫師邀請該院之疾病

分類人員一起參加。

23


台南大億麗緻酒店五樓常紅廳

Victory Room (5F), Tayih Landis Tainan

１０６年度戒煙治療醫師教育訓練基礎課程

08:50 報到及前測(Pre-test)

09:10 心血管疾病防治與戒菸服務………………………………………………...王英偉

(衛生福利部國民健康署)

10:00 休息

10:10 戒菸的藥物治療………………………………………………………………陳念中

(敏盛綜合醫院)

11:00 休息

11:10 冠心病臨床個案之戒菸治療技巧……………………………………………周禎穎

(彰化基督教醫療財團法人鹿港基督教醫院)

12:00 後測(Post-test)

23

23


台南大億麗緻酒店五樓常紅廳

Victory Room (5F), Tayih Landis Tainan

１０６年度戒煙治療醫師教育訓練基礎課程

08:50 報到及前測(Pre-test)

09:10 心血管疾病防治與戒菸服務………………………………………………...王英偉

(衛生福利部國民健康署)

10:00 休息

10:10 戒菸的藥物治療………………………………………………………………陳念中

(敏盛綜合醫院)

11:00 休息

11:10 冠心病臨床個案之戒菸治療技巧……………………………………………周禎穎

(彰化基督教醫療財團法人鹿港基督教醫院)

12:00 後測(Post-test)

24

1




SATELLITE SYMPOSIUM：AN EMDURING, BOLD AMBITION TO BREAK

THROUGH CONVENTIONAL THINKING IN CARDIOVASCULAR AND

METABOLIC HEALTH

﹝AstraZeneca﹞

12:15 Opening Remarks………………………………………………...………………………方慶章

(Ching-Chang Fang)

Chair: 方慶章 (Ching-Chang Fang)

12:20 The Appropriate DAPT Duration for Acute Coronary Disease Patients………….李貽恆

(Yi-Heng Li)

Chair: 鄭正一 (Cheng-I Cheng)

12:55 In-Depth Exploration of SGLT2 Inhibitors: Clinical Impact and

Underlying Mechanisms…………………………………………..……….…..……….吳彥雯

(Yen-Wen Wu)

13:30 Panel Discussion & Closing Remarks…………………………………………………鄭正一 (Cheng-I Cheng)

25

1




SATELLITE SYMPOSIUM：AN EMDURING, BOLD AMBITION TO BREAK

THROUGH CONVENTIONAL THINKING IN CARDIOVASCULAR AND

METABOLIC HEALTH

﹝AstraZeneca﹞

12:15 Opening Remarks………………………………………………...………………………方慶章

(Ching-Chang Fang)

Chair: 方慶章 (Ching-Chang Fang)

12:20 The Appropriate DAPT Duration for Acute Coronary Disease Patients………….李貽恆

(Yi-Heng Li)

Chair: 鄭正一 (Cheng-I Cheng)

12:55 In-Depth Exploration of SGLT2 Inhibitors: Clinical Impact and

Underlying Mechanisms…………………………………………..……….…..……….吳彥雯

(Yen-Wen Wu)

13:30 Panel Discussion & Closing Remarks…………………………………………………鄭正一 (Cheng-I Cheng)

2




SATELLITE SYMPOSIUM:

THE NEW BETA-BLOCKER, EXPAND HORIZONS

﹝Menarini﹞

12:15 Chair: 劉秉彥 (Ping-Yen Liu)

12:20 Latest Trends in Hypertension Management ─

A New Vasodilating Beta-blocker Nebivolol……………………..….Giuseppe Mancia


26

3





REVIVE FROM THE CORNER TO GLORY -

THE LAST FIGHTER OF PPAR-GAMMA AGONIST

﹝Takeda﹞

12:15 Chair: 溫明賢(Ming-Shien Wen)

12:20 TZD: How the Only Insulin-Sensitizer Fits into Modern Treatment?……………曾慶孝

(Chin-Hsiao Tseng)


27

3





REVIVE FROM THE CORNER TO GLORY -

THE LAST FIGHTER OF PPAR-GAMMA AGONIST

﹝Takeda﹞

12:15 Chair: 溫明賢(Ming-Shien Wen)

12:20 TZD: How the Only Insulin-Sensitizer Fits into Modern Treatment?……………曾慶孝

(Chin-Hsiao Tseng)


4




SATELLITE SYMPOSIUM: FROM PARADIGM-HF TO

CLINICAL PRACTICE

﹝Novartis﹞

17:45 Opening Remarks……………………………………………………………………….王俊傑

(Chun-Chieh Wang)

Chair: 王俊傑(Chun-Chieh Wang)

17:50 Paradigm-HF: Most Asked Questions about ARNI…………………………….......林宗憲

(Tsung-Hsien Lin)

Chair: 鄭書孟(Shu-Meng Cheng)

18:10 Clinical Practice: My Clinical Experiences to Date…………………………………..方慶章

(Ching-Chang Fang)

Chair: 劉言彬(Yen-Bin Liu)

18:30 Clinical Practice: My Clinical Experiences to Date…………………………………..白培英

(Pei-Ying Pai)


19:10 Closing Remarks…………………………………………………………………….......劉言彬

(Yen-Bin Liu)

28

5




SATELLITE SYMPOSIUM：THE HEALTHY EFFECTS OF SMOKING CESSATION ON

CARDIOVASCULAR EVENTS

﹝Pfizer﹞

17:45 Opening Remarks……………………………………………………………………….林俊立

(Jiunn-Lee Lin)

Chair: 林俊立 (Jiunn-Lee Lin)

17:50 The Healthy Effects of Smoking Cessation on Cardiovascular Events………......蘇大成

(Ta-Chen Su)


29

5




SATELLITE SYMPOSIUM：THE HEALTHY EFFECTS OF SMOKING CESSATION ON

CARDIOVASCULAR EVENTS

﹝Pfizer﹞

17:45 Opening Remarks……………………………………………………………………….林俊立

(Jiunn-Lee Lin)

Chair: 林俊立 (Jiunn-Lee Lin)

17:50 The Healthy Effects of Smoking Cessation on Cardiovascular Events………......蘇大成

(Ta-Chen Su)


6




SATELLITE SYMPOSIUM: THE OVERVIEW TRIAL OF EVOLOCUMAB ─

PROFICIO PROGRAMME

﹝Amgen﹞

12:15 Chair: 葉宏一(Hung-I Yeh)

12:20 The Overview Trial of Evolocumab─Proficio Programme………………………...謝宜璋

(I-Chang Hsieh)


30

7




SATELLITE SYMPOSIUM: PATIENT FIRST ─ INTERACTIVE CASE

DISCUSSION: EVALUATE VHD AF PATIENTS WITH GENERAL

SURGICAL INTERVENTION

﹝Pfizer﹞

12:15 Chair: 郭啟泰(Chi-Tai Kuo)

12:20 Interactive Case Discussion: Evaluate VHD AF Patients with General

Surgical Intervention…………………………………………………………………….詹益欣

(Yi-Hsin Chan)


31

7




SATELLITE SYMPOSIUM: PATIENT FIRST ─ INTERACTIVE CASE

DISCUSSION: EVALUATE VHD AF PATIENTS WITH GENERAL

SURGICAL INTERVENTION

﹝Pfizer﹞

12:15 Chair: 郭啟泰(Chi-Tai Kuo)

12:20 Interactive Case Discussion: Evaluate VHD AF Patients with General

Surgical Intervention…………………………………………………………………….詹益欣

(Yi-Hsin Chan)


社團法人中華民國心臟學會2017冬季學術研討會

贊助廠商

Diamond輝瑞生醫股份有限公司

Platinum台灣武田藥品工業股份有限公司

Gold台灣諾華股份有限公司

新加坡商美納里尼醫藥有限公司台灣分公司

Silver台灣阿斯特捷利康股份有限公司

台灣百靈佳殷格翰股份有限公司

Bronze台灣安進藥品有限公司

Friends美商默沙東藥廠股份有限公司台灣分公司

台灣第一三共股份有限公司

安沛國際有限公司

瑞士商瑞士銀行股份有限公司

友華生技醫藥股份有限公司

東生華製藥股份有限公司

愛可泰隆醫藥技術有限公司

信文達股份有限公司

賽諾菲股份有限公司

台灣拜耳股份有限公司

荷商波士頓科技有限公司台灣分公司

敬賀大會圓滿成功

Taiwan Society of Cardiology¯€目表 ok.pdfLiang-Miin Tsai Chen-Chuan Cheng 理事: Executives:...

Documents

Transcript of Taiwan Society of Cardiology¯€目表 ok.pdfLiang-Miin Tsai Chen-Chuan Cheng 理事: Executives:...